Know Labs (OTCMKTS:KNWN – Get Rating) is one of 28 publicly-traded companies in the “Measuring & controlling devices, not elsewhere classified” industry, but how does it weigh in compared to its rivals? We will compare Know Labs to similar companies based on the strength of its analyst recommendations, dividends, valuation, risk, earnings, profitability and institutional ownership.
This table compares Know Labs and its rivals’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Know Labs Competitors||-3,288.70%||4.83%||1.80%|
This table compares Know Labs and its rivals gross revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|Know Labs||$120,000.00||-$25.36 million||-1.90|
|Know Labs Competitors||$2.66 billion||$435.24 million||11.14|
Know Labs’ rivals have higher revenue and earnings than Know Labs. Know Labs is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.
Insider & Institutional Ownership
10.6% of Know Labs shares are owned by institutional investors. Comparatively, 61.0% of shares of all “Measuring & controlling devices, not elsewhere classified” companies are owned by institutional investors. 44.0% of Know Labs shares are owned by company insiders. Comparatively, 16.1% of shares of all “Measuring & controlling devices, not elsewhere classified” companies are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Risk & Volatility
Know Labs has a beta of 3.04, indicating that its share price is 204% more volatile than the S&P 500. Comparatively, Know Labs’ rivals have a beta of 1.03, indicating that their average share price is 3% more volatile than the S&P 500.
This is a summary of recent ratings and recommmendations for Know Labs and its rivals, as provided by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Know Labs Competitors||154||689||953||28||2.47|
Know Labs presently has a consensus price target of $7.00, indicating a potential upside of 360.53%. As a group, “Measuring & controlling devices, not elsewhere classified” companies have a potential upside of 28.25%. Given Know Labs’ stronger consensus rating and higher probable upside, research analysts clearly believe Know Labs is more favorable than its rivals.
Know Labs rivals beat Know Labs on 7 of the 13 factors compared.
About Know Labs (Get Rating)
Know Labs, Inc. focuses on the development and commercialization of proprietary technologies in the United States. Its technology uses spectroscopy to direct electromagnetic energy through a substance or material to capture a molecular signature. The company refers to its technology as Bio-RFID. The Bio-RFID technology can be integrated into various wearable, mobile, or bench-top form factors. Its first application of Bio-RFID technology is a product marketed as a glucose monitor that provide the user with real time information on their blood glucose levels. The company was formerly known as Visualant, Incorporated and changed its name to Know Labs, Inc. in May 2018. Know Labs, Inc. was founded in 1998 and is headquartered in Seattle, Washington.
Want More Great Investing Ideas?
- Bear Market Game Plan!
- The 10 Best Stocks to Own in 2022
- 7 Stocks to Buy and Hold Forever
- 3 Stocks to DOUBLE This Year
Receive News & Ratings for Know Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Know Labs and related companies with MarketBeat.com's FREE daily email newsletter.